@loriesco, hey, don't blame me.
It was probably me, but I would have sent https://www.biospace.com/radius-announces-update-on-tymlos-abaloparatide-label
Protocol is rigid--rules that must be followed. Various osteoporosis associations offer guidelines as do the manufacturers pamplets. Doctors have license to vary from guidelines.
I may have even sent the link you cite at another time, but it is about Forteo, you see.